NPCE logo

NeuroPace (NPCE) Selling, General & Administrative Expenses

NPCE Annual SG&A

$54.52 M
+$3.18 M+6.19%

31 December 2023

NPCE Selling, General & Administrative Expenses Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

NPCE Quarterly SG&A

$13.91 M
-$390.00 K-2.73%

30 September 2024

NPCE Quarterly SG&A Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

NPCE TTM SG&A

-$2.06 B
-$28.09 M-1.38%

30 September 2024

NPCE TTM SG&A Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

NPCE Selling, General & Administrative Expenses Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+6.2%+3.9%-3858.7%
3 y3 years+97.3%+3.9%-3858.7%
5 y5 years+80.5%+3.9%-3858.7%

NPCE Selling, General & Administrative Expenses High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+39.9%-7.9%+18.4%-25.9%at low
5 y5-yearat high+97.3%-7.9%+147.7%-432.0%at low
alltimeall timeat high+97.3%-7.9%+147.7%-432.0%at low

NeuroPace Selling, General & Administrative Expenses History

DateAnnualQuarterlyTTM
Sept 2024
-
$13.91 M(-2.7%)
$56.53 M(+0.9%)
June 2024
-
$14.30 M(-5.3%)
$56.01 M(-0.3%)
Mar 2024
-
$15.10 M(+14.3%)
$56.19 M(+3.1%)
Dec 2023
$54.52 M(+6.2%)
$13.22 M(-1.3%)
$54.52 M(-0.6%)
Sept 2023
-
$13.39 M(-7.6%)
$54.87 M(+1.5%)
June 2023
-
$14.48 M(+7.9%)
$54.04 M(+3.3%)
Mar 2023
-
$13.43 M(-1.1%)
$52.33 M(+1.9%)
Dec 2022
$51.34 M
$13.57 M(+8.1%)
$51.34 M(+3.7%)
Sept 2022
-
$12.55 M(-1.7%)
$49.51 M(+6.8%)
June 2022
-
$12.77 M(+2.6%)
$46.38 M(+7.5%)
DateAnnualQuarterlyTTM
Mar 2022
-
$12.44 M(+5.9%)
$43.14 M(+10.7%)
Dec 2021
$38.96 M(+41.0%)
$11.75 M(+24.7%)
$38.96 M(+12.9%)
Sept 2021
-
$9.42 M(-1.1%)
$34.50 M(+7.4%)
June 2021
-
$9.53 M(+15.2%)
$32.13 M(+13.9%)
Mar 2021
-
$8.27 M(+13.5%)
$28.21 M(+2.1%)
Dec 2020
$27.63 M(-8.5%)
$7.28 M(+3.3%)
$27.63 M(+35.8%)
Sept 2020
-
$7.05 M(+25.6%)
$20.35 M(+53.0%)
June 2020
-
$5.62 M(-26.9%)
$13.30 M(+73.1%)
Mar 2020
-
$7.68 M
$7.68 M
Dec 2019
$30.20 M
-
-

FAQ

  • What is NeuroPace annual selling, general & administrative expenses?
  • What is the all time high annual SG&A for NeuroPace?
  • What is NeuroPace annual SG&A year-on-year change?
  • What is NeuroPace quarterly selling, general & administrative expenses?
  • What is the all time high quarterly SG&A for NeuroPace?
  • What is NeuroPace quarterly SG&A year-on-year change?
  • What is NeuroPace TTM selling, general & administrative expenses?
  • What is the all time high TTM SG&A for NeuroPace?
  • What is NeuroPace TTM SG&A year-on-year change?

What is NeuroPace annual selling, general & administrative expenses?

The current annual SG&A of NPCE is $54.52 M

What is the all time high annual SG&A for NeuroPace?

NeuroPace all-time high annual selling, general & administrative expenses is $54.52 M

What is NeuroPace annual SG&A year-on-year change?

Over the past year, NPCE annual selling, general & administrative expenses has changed by +$3.18 M (+6.19%)

What is NeuroPace quarterly selling, general & administrative expenses?

The current quarterly SG&A of NPCE is $13.91 M

What is the all time high quarterly SG&A for NeuroPace?

NeuroPace all-time high quarterly selling, general & administrative expenses is $15.10 M

What is NeuroPace quarterly SG&A year-on-year change?

Over the past year, NPCE quarterly selling, general & administrative expenses has changed by +$521.00 K (+3.89%)

What is NeuroPace TTM selling, general & administrative expenses?

The current TTM SG&A of NPCE is -$2.06 B

What is the all time high TTM SG&A for NeuroPace?

NeuroPace all-time high TTM selling, general & administrative expenses is $56.53 M

What is NeuroPace TTM SG&A year-on-year change?

Over the past year, NPCE TTM selling, general & administrative expenses has changed by -$2.12 B (-3858.73%)